IDEX Biometrics ASA Announces New Share Issuance
IDEX Biometrics ASA is excited to share its decision to issue 299,381,600 new shares at a nominal value of NOK 0.01 per share. This issuance, aimed at employees, contractors, and directors within the IDEX family, supports the ongoing efforts to implement the company's refined business strategy and boost product commercialization.
Details of the Share Issuance
The resolution for this significant share placement aligns with a previous decision made during the extraordinary general meeting where the board was granted authorization to issue shares on terms related to a previously approved debt conversion. The goal is to recognize and incentivize the personnel while nurturing a shared commitment to the company’s growth.
Share Restrictions and Terms
All newly issued shares will be subject to a restriction period of 18 months, during which they cannot be sold or transferred. After six months, one-third of these shares will be released, and another third after twelve months. Moreover, if an employee resigns or is terminated, IDEX has the right to repurchase the restricted shares under specified conditions.
Compliance and Fairness Considerations
In issuing these shares, the board has carefully considered compliance with equal treatment obligations mandated by various regulations, including the Norwegian Securities Trading Act. The proposed placement is viewed favorably, ensuring that it serves the common interest of the company and its shareholders.
Effects on Existing Shareholders
The number of new shares represents approximately 6.7% of the total outstanding shares, which the board believes will limit the potential dilution effect among existing shareholders. With a subscription price presented at NOK 0.01, there exists a substantial discount in relation to the closing share price prior to issuance. This discount accounts for the lock-up period and projected share price movements.
Future Company Structure
Upon registration of the increased share capital, IDEX Biometrics will stand at a total share capital of NOK 47,310,125.99, which breaks down to 4,731,012,599 shares each valued at NOK 0.01. This strategic maneuver underscores IDEX’s commitment to growth while maintaining the integrity of shareholder investments.
Contact Information
For further inquiries, stakeholders can reach out to Kristian Flaten, CFO, at +47 950 92322 or via email at ir@idexbiometrics.com.
About IDEX Biometrics
IDEX Biometrics ASA (IDEX) is a world-renowned leader in fingerprint biometrics, offering innovative solutions for payment processing, access control, and digital identity verification. Their technology is designed to enhance user convenience, security, and overall experience, built on unique sensor technologies and integrated software solutions. Working alongside key card manufacturers and tech developers, IDEX continues to expand its market reach.
Frequently Asked Questions
What is the purpose of the new share issuance by IDEX?
The purpose is to incentivize personnel in implementing the company's refreshed business plan and facilitate the commercialization of its products.
How many shares are being issued to personnel?
IDEX Biometrics is issuing 299,381,600 new shares as part of this initiative.
What are the restrictions on the issued shares?
The shares are restricted for 18 months and may be subject to a reverse vesting schedule for those who leave the company.
How does this issuance affect existing shareholders?
The issuance represents approximately 6.7% of outstanding shares, limiting potential dilution for existing shareholders.
Who can be contacted for more information regarding this share issuance?
Kristian Flaten, the CFO, is the designated contact person for inquiries about the share issuance.
